The Improvement of Sepsis-Associated Encephalopathy by P2X7R Inhibitor through Inhibiting the Omi/HtrA2 Apoptotic Signaling Pathway

The pathogenesis of sepsis-associated encephalopathy (SAE) involves many aspects, including intracellular peroxidative stress damage, mitochondrial dysfunction, and cell apoptosis. In this study, we mainly explored the influence of P2X7R on the cognitive function of SAE and its molecular mechanism. We established a sepsis model using lipopolysaccharide (LPS) stimulation, followed by an assessment of cognitive function using Morris water maze, and then Western Blot was used to analyze the expression of tight junction proteins ZO-1 and Occludin in the hippocampus of mice. TUNEL assay was used to analyze the apoptosis of brain cells in frozen brain slices of mice during sepsis. Human brain microvascular endothelial cells (HBMECs) were used to research the molecular mechanism of brain cell damage induced by P2X7R. The results showed that P2X7R inhibitors dramatically improved the survival rate of mice, relieved the cognitive dysfunction caused by LPS stimulation, and significantly reduced the brain cell apoptosis caused by LPS. In addition, the inhibition of P2X7R can also reduce the production and accumulation of reactive oxygen species (ROS) in HBMECs in vitro and inhibit the apoptosis signaling pathway associated with mitochondrial serine protease Omi/HtrA2 in HBMECs in vitro. These results suggest that P2X7R has strong value as a potential target for the treatment of SAE.


Introduction
SAE is an inflammatory infection that causes systemic sepsis to spread to the brain, but there is no evidence of direct infection in the brain, and this is one reason for long-term and short-term cognitive impairment and high mortality in sepsis patients in the ICU [1,2]. More and more evidences show that SAE is closely related to peroxidation stress injury of brain cells, mitochondrial dysfunction, and apoptosis. Some researchers have found that 70% of severe sepsis survi-vors are accompanied by cognitive impairment [3,4], but the pathogenesis of SAE is still unclear.
As a member in the P2X family of ATP-sensitive purinergic receptors, P2X7R is unique in that it only functions in homomeric forms and is activated by high extracellular ATP levels [5]. Activation of P2X7R causes a large amount of Ca2+ and Na+ influx and K+ outflow, resulting in the imbalance of intracellular metabolism. P2X7R is primarily expressed on the surface of various brain cells, especially microglia and astrocytes [6,7]. Many scholars regard P2X7R as a receptor closely related to inflammatory injury, because P2X7R located in various organs of the body will be greatly activated when severe systemic infection occurs and the activation of P2X7R is also a damaging process [8]. In this regard, whether the brain damage caused by the activation of P2X7R in the brain can be considered as one of the mechanisms of SAE, and the molecular mechanisms in brain cells caused by the activation remain to be explored.
The blood-brain barrier (BBB) is a gateway through which the brain and the outside world exchange substances, allowing small molecules of nutrients and oxygen to enter the brain, while blocking harmful macromolecules from entering the brain [9]. It is well known that the BBB is mainly composed of cerebral capillary endothelial cells, basal membrane and foot processes of glial cells, and tight junction proteins produced by endothelial cells play a crucial role in the cell-cell connection of BBB and maintaining the integrity of BBB [10]. When harmful substances, such as lipopolysaccharide (LPS), arrive at BBB with blood flow, they will first damage endothelial cells, thereby inhibiting the expression of tight junction protein and damaging BBB [11]. However, it remains to be explored whether LPS-induced brain endothelial cell damage is related to P2X7R activation and whether inhibition of P2X7R has a protective effect.
Under normal physiology, the body's physiological metabolism will produce an appropriate amount of ROS, acting as a signal to regulate the physiological and biochemical reactions inside and outside cells of the body [12]. However, when the body suffers pathological injuries, such as invasion of external bacteria and reperfusion injury caused by ischemia and hypoxia of essential organs, the damaged organs will produce and accumulate ROS in large quantities. The accumulation of ROS in cells will destroy important organelles such as endoplasmic reticulum and mitochondria, even directly damage the DNA of cells [13,14]. At present, many studies have found that the continuous production of ROS is closely associated with neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease [15], as well as cell necrosis and apoptosis related to inflammation [16]. Although recent studies have found that the activation of P2X7R can induce ROS production in cardiomyocytes [17], the effect of P2X7R on the production of ROS in brain cells after severe sepsis-induced SAE remains to be explored. In addition, numerous studies have found that plenty of intracellular ROS can cause intracellular apoptosis related to caspase, Bcl-2, and cytochrome C [18]. However, whether ROS production can cause apoptosis related to mitochondrial serine protease Omi/HtrA2 remains unexplored.
Both apoptosis and programmed cell death occur in all organs of the body and maintain a balance between the removal of damaged cells and the renewal of new cells [19]. However, when the body is subjected to severe damaging stimuli, such as the disturbance of the body's internal environment caused by inflammation or biochemical stimulation, the cells of the body will undergo apoptosis caused by aspartate-specific cysteine proteases known as caspases. Cell apoptosis is closely related to mitochondria besides some signaling pathways in the cytoplasm [20]. Apoptosis caused by mitochondrial pathway is mainly related to the mito-chondrial serine protease Omi/HtrA2, which exists in the inner and outer membrane of mitochondria under physiological conditions and is mainly involved in clarifying misfolded proteins in mitochondria [21,22]. However, when cells are injured by various pathological factors such as external inflammation, biochemical and physiological changes will occur in the cells, thereby transferring Omi/ HtrA2 from the mitochondrial intermembrane space into the cytoplasm [23,24]. Nonetheless, it is still unclear whether the activation of P2X7R on the cell surface will affect the membrane potential of mitochondria and whether it will cause the transfer of Omi/HtrA2 from mitochondrial to cytoplasmic.
Apoptosis-related proteins XIAP, Caspase9, and Cas-pase3 play a vital role in the process of cell apoptosis [25]. As a member in the evolutionarily conserved family of inhibitors of apoptosis proteins (IAPs), X-linked inhibitor of apoptosis protein (XIAP) can bind and inhibit caspaserelated apoptosis in cells [26]. When Omi/HtrA2 enters the cytoplasm from mitochondria, XIAP will be degraded, thus, inhibiting the degradation of caspase-9 by XIAP [27][28][29], and increased expression of caspase-9 activates caspase-3, ultimately causing intracellular DNA damage. It has been proved that cell apoptosis induced by external damaging stimuli is significantly reduced after mitochondrial serine protease Omi/HtrA2 is knocked down [30]. Therefore, the effect of P2X7R activation on XIAP and caspase-3-related apoptosis needs further exploration.

Animal
Feeding and Animal Experiment. After obtaining the male C57BL/6 (8-10 weeks) mice from Medical Laboratory Animal Center of Weifang Medical University, they were allowed to adapt for seven days. The mice lived in a quiet room, with the rotation of dark and light every 12 hours, the room temperature of 25°C, and free access to food and water every day in the cage. All animal operations were conducted following ethical regulations and laboratory guidelines. To test whether A-438079 could affect LPSinduced SAE and cognitive function in mice, LPS was dissolved in PBS, and A-438079 was dissolved with 25% dimethyl sulfoxide (DMSO) (Sigma-Aldrich, USA). Then, the mice were divided into four groups. Control group mice were intraperitoneally injected with PBS of the same volume as LPS group. LPS group was injected intraperitoneally LPS (5 mg/kg), LPS + A − 438079 group was intraperitoneally injected with A-438079 (30 mg/kg) after one hour of pretreatment with LPS (5 mg/kg), LPS + DMSO group was intraperitoneally injected with DMSO after one hour of pretreatment with LPS (5 mg/kg). Body weight and the survival rate of the mice were recorded daily for 7 days (each group contained five mice), after that, the mice were decapitated and their brains were taken under pentobarbital anesthesia, and proteins were extracted from their hippocampal tissues for subsequent experiments. However, for behavioral tests, three days after the injection, behavioral tests were performed on each group of mice to determine the success of the model and the changes in cognitive function (each group contained ten mice). After the behavioral test (day 7 after LPS injection), the mice were placed under pentobarbital anesthesia with a heart infused with normal saline followed by 4% paraformaldehyde fixation and decapitated. Mouse brain tissue was immobilized in 4% paraformaldehyde for 4 h and then placed in 15% sucrose solution until the brain tissue sank to the bottom. The brain tissue was taken out, and frozen sections were performed after OTC embedding. The brain slices were stored at -20°C. The cells were cultured in DMEM medium of 30 mg/ml endothelial growth factor, 10% fetal bovine serum, and 10 mg/ml penicillin/streptomycin. Cells were cultured at 5% CO2 and 37°C. The culture medium was changed every 24 hours, and it was passed after 48 hours. Before LPS treatment, the cells were inoculated in a six-well plate at a density of 1 × 10 5 cells/well and placed in an incubator overnight. On the second day, cells were pretreated with A-438079 (2.5 μg/ml) or DMSO, and LPS (5 μg/ml) was added one hour later in each group. After 12 hours of culture, the cells were collected for Western Blot analysis.

ROS Assay.
The production of ROS in HBMEC was analyzed by DCFH-DA staining. According to the protocol of the manufacturer, DCFH-DA and DMEM are configured in quantities of 1 : 1000. The cells were inoculated in a sixwell plate at a density of 1 × 10 5 cells/well, and drugs are treated in line with the above cell treatment protocol, then, each well was added with 1 ml and incubated at 37°C for 40 minutes. Finally, ROS production in each group of cells was filmed by fluorescence microscopy (Olympus, Japan).

Mitochondrial Membrane Potential Analysis.
We used Mito-Tracker Red CMXRos aggregation in mitochondria which depends on the characteristics of mitochondrial membrane potential to analyze the changes of mitochondrial membrane potential in different groups of cells. Briefly, HBMECs were inoculated in a six-well plate with preplaced circular slides overnight, followed by abandoning culture and adding 1 : 1000 Mito-Tracker Red CMXROS (purchased from Beyotime) working fluid to the preprepared medium at 37°C for 15-30 minutes, and finally, DAPI was added, with each group of cells filmed by fluorescence microscopy (Olympus, Japan).
2.6. Western Blot Analyses. Western Blot was roughly divided into four steps. The first step was electrophoresis. After adding the sample of each group to the electrophoresis tank, the electrophoretic liquid was added, and the electrophoresis is performed at 80 V for 30 minutes first, then, at 120 V for 60 minutes. In the second step of membrane trans-fer, the separation gel after electrophoresis was placed in a membrane transfer clamp with sponge and filter paper to transfer the membrane for 90 minutes in a transfer tank with the transfer solution at 300 mA. The third step was seal and incubation. After membrane transfer, the nitocellulose membrane was transferred to 5% skim milk powder for sealing for 2 hours, then, incubated overnight in the primary antibody at 4°C and in the secondary antibody at room temperature for 1-1.5 hours the next day. Fourth, ECL solution (purchased from Beyond) was added to the immunoreactive membrane and developed using Enhanced Chemiluminescent Detection. Results analysis: ImageJ software was used to analyze the gray value of the strip.
2.7. TUNEL Assay. The TUNEL fluorescence assay kit was used to detect apoptosis in frozen brain sections, i.e., a well-preserved frozen brain section was placed in a citrate solution in a microwave oven on high heat for 5 minutes, followed by medium heat for 10 minutes for percolation. Then, the section was washed three times with PBS solution and incubated for 60 min at 37°C under darkroom conditions after adding preconfigured TUNEL working solution (I solution : II solution = 1 : 9), followed by being washed three times with PBS and added DAPI to seal. TUNELpositive cells were counted using image analysis software (Image-Pro Plus 6.0) under identical conditions, and each group of cells was recorded by fluorescence microscopy (Olympus, Japan).

Morris Water
Maze. An operator who was not aware of each treatment group detected the cognitive function of mice by Morris water maze (MWM). The MWM consisted of a circular steel pool (125 cm in mice by Morris water maze (MWM)). The MWM consisted of a circular steel pool (125 cm in diameter, 60 cm in depth) with water depth below 1 cm above the top of the platform (10 cm in diameter, 30 cm in height). The pool was surrounded by a gray curtain and placed in a quiet room at 25°C with titanium dioxide to make the water turbid. MWM testing began on the third day after LPS or A-438079 treatment and lasted for five days, with the first 4 days (3-6 days) being a training period. The mice were released from various locations and given 60 seconds to find the platform, and they were artificially led to the platform and stayed there for 15 seconds if they failed to find the platform. A video surveillance system was used to record and track the escape latency of mice (i.e., the time taken from being placed in the water to finding the platform). On the 5th day (day 7), the mice were subjected to the space exploration experiment. The platform was removed, and the mice were released from the opposite side of the platform and swam free for 120 seconds, with the number of target crossings recorded.
2.9. Statistical Analyses. All data are presented in the meanstandard deviation, with their validation analyses were performed by SPSS24.0 (SPSS Inc., Chicago, IL). P < 0:05 was considered statistically significant. Differences among the groups were examined by one-way analysis of variance.

P2X7R Inhibitors Can Increase the Survival Rate and
Improve Cognitive Dysfunction in Mice with SAE. At present, little is known about the pathogenesis of SAE. Many studies have found that cells in the brain undergo apoptosis under the stimulation of inflammatory factors, which is crucial for the pathogenesis of SAE. Since P2X7R is a receptor closely associated with inflammation and amplifies inflammatory damage, we investigated the influence of P2X7R inhibitor A-438079 on cognitive function in mice after severe sepsis was induced by LPS.
The results showed a significant weight loss after treatment with LPS compared to the control group, whereas the pretreated LPS group treated with A-438079 did not indicate a significant weight loss (Figure 1(a)). Similarly, we found a significant decrease in survival in mice after several weeks of LPS treatment compared to the control group, but pretreatment with A-438079 could reverse the LPSinduced low survival in mice (Figure 1(b)). When mice were trained for MWM (3-6 days), we found that the distance to the platform was significantly longer after LPS or LPS + DMSO treatment compared to the control group, while the distance was dramatically shortened after A-438079 The distance traveled by each group to reach the platform during the training period. Mice traveling distance was significantly reduced after treatment with A-438079 compared with the LPS and LPS+ DMSO groups. (d) Mice in LPS groups and LPS + DMSO groups expressed a signally longer escape latency than the control group. Treatment with A-438079 significantly reduced the extension of the escape latency after LPS treatment, n = 5. All data are expressed as mean ± SD. * * P < 0:01 vs. control, # P < 0:05 vs. LPS group, and @@ P < 0:01 vs. LPS + A − 438079 group. (e) The number of times the mice crossed the platform was significantly reduced in the LPS group compared with the control group but increased after treatment with A-438079 compared with the LPS group, moreover, the number of mice crossing the platform in the LPS + DMSO group was significantly decreased compared with the LPS + A − 438079 group; n = 5. All data are expressed as mean ± SD. * * P < 0:01 vs. control, ## P < 0:01 vs. LPS group, and @@ P < 0:01 vs. LPS + A − 438079 group. treatment compared with those in LPS and LPS + DMSO groups (Figure 1(c)). Moreover, mice in the LPS treatment group and the LPS + DMSO group took notably longer to reach the platform during the training period than those in the control group, and the result was reversed after A-438079 treatment (Figure 1(d)). Then, the spatial memory test was performed on day 7 by removing the platform, releasing the mice from the quadrant facing the platform, and recording the number of times the mice crossed the platform area within 120 seconds. We found that the number of platform crossings was significantly reduced in the LPS group and the LPS + DMSO group compared with the control group, while the number in the A-438079 group was higher than that in the LPS and LPS + DMSO groups (Figure 1(e)).
From the above findings, we can find that LPS injection does cause cognitive impairment and lead to SAE in mice, while treatment with P2X7R inhibitor can improve the loss of spatial memory and directional learning abilities in mice. These results suggest that P2X7R plays a crucial role in the pathogenesis of SAE.

P2X7R Inhibitors Ameliorate LPS-Induced Tight
Junction Protein Reduction in the Mouse Hippocampus. In order to verify the protective effect of P2X7R inhibitor on BBB in the hippocampal area of mice after LPS treatment, we extracted the protein from the hippocampal tissue of mice and detected the expression of tight junction protein in each group by Western Blot. The results showed that LPS treatment significantly increased the expression of P2X7R in the hippocampus of mice (Figures 2(a) and 2(b)), and compared with the control group, LPS treatment significantly reduced the expression of tight junction protein Occludin and ZO-1, while LPS + A − 438079 group reversed this effect (Figures 2(a), 2(c), and 2(d)). From these results, it is clear that P2X7R plays a key role in LPS-induced BBB damage in mice.

P2X7R Inhibitors Can Attenuate the ROS Production and Changes in Mitochondrial Membrane Potential in
HBMECs Induced by LPS Stimulation In Vitro. As the activation of P2X7R will lead to a large increase in intracellular Ca 2+ level, HBMEC cells cultured in vitro were selected and given LPS or P2X7R inhibitor A-438079 to research the effect of P2X7R activation on intracellular mitochondrial membrane potential and ROS production. Then, the production of ROS in HBMECs was analyzed by DCFH-DA

Behavioural Neurology
staining, and the fluorescence intensity of each group was analyzed by ImageJ. The results showed that HBMECs produced more ROS when stimulated by LPS than by normal saline alone, and this phenomenon was reversed by P2X7R inhibitor A-438079 (Figures 3(b) and 3(c)). Since A-438079 was dissolved in DMSO, we found that the LPS + DMSO group was not statistically significant compared with the LPS group.
Since the fluorescence emitted by Mito-tracker Red CMXROS is dependent on mitochondrial membrane potential, we then used Mito-tracker Red CMXROS in HBMECs in vitro to evaluate the intracellular mitochondrial membrane potential. We found that the fluorescence signal intensity of the LPS stimulation group alone or the LPS + DMSO group was observably decreased than that of the control group and the LPS + A − 438079 group (Figure 3(a)). It can be seen that when brain cells are stimulated by inflammation, P2X7R inhibitors can reduce intracellular ROS production and have a protective effect on mitochondria.

LPS Stimulation Induced the Transfer of Omi/HtrA2 from Mitochondria to the Cytoplasm In Vitro and P2X7R
Inhibitors Inhibited This Process. We speculated that the large influx of calcium ions caused by P2X7R activation would lead to the apoptosis of mitochondrial pathways, i.e., the Omi/HtrA2 protease generally presented in the mitochondria probably be transferred into the cytoplasm under the inflammation stimuli. Therefore, we explored the  (Figures 4(a) and 4(c)). Nevertheless, the LPS-induced transfer of Omi/HtrA2 to the cytoplasm was reversed after the treatment of A-438079. (Figures 4(a)-4(d)).
These results indicate that P2X7R expression in cells is significantly increased under inflammatory stimulation, and P2X7R inhibitors can alleviate the cytoplasmic translocation of apoptosis-related protein Omi/HtrA2 in mitochondria   Previous studies have shown that XIAP can inhibit apoptosis by degrading apoptotic protein caspase-3 and caspase-9, while Omi/HtrA2 protease mainly degrades XIAP and thus leading to increased activation of caspase-3 and caspase-9. Therefore, in sepsis-associated encephalopathy caused by LPS, P2X7R activation may induce the brain cell apoptosis through the Omi/HtrA2 protease signaling pathway.
In order to identify the impact of P2X7R inhibitor on apoptosis-related proteins, the expression of apoptosis inhibiting protein XIAP was detected by Western Blot. As previously predicted, the level of XIAP in HBMECs was significantly higher in the inhibitor A-438079 group than in the LPS (Figures 4(e) and 4(f)).

P2X7R Inhibitors A-438079 Alleviated Apoptosis of Brain Cells after LPS Stimulation In Vivo and Reduced Cleaved
Caspase-3 and Cleaved Caspase-9 Expression. Caspases are a class of cysteine proteases that exist in the cytoplasm and play an important role in the upstream and downstream of cell death signaling pathways. Caspase-9, for example, is activated by self-shearing in response to a stimulus signal, which in turn activates downstream apoptotic agents such as Caspase-3.
In order to explore the molecular mechanism of P2X7R induced apoptosis of brain cells by LPS stimulation, we first pretreated microglia with P2X7R inhibitor A-438079 in vitro, followed by LPS stimulation. The expression of cleaved-Caspase-9 and cleaved-Caspase-3 in the LPS + A − 438079 groups was decreased compared with the LPS and LPS + DMSO groups (Figures 5(a)-5(d)), while these two indicators were not statistically significant in the inhibitor A-438079 group compared with the control group ( Figures 5(a)-5(d)). In order to observe the effect of LPS and A-438079 on the brain cell apoptosis in mice, we further selected frozen brain sections of mice for TUNEL staining. The results demonstrated that a large number of brain cell apoptosis occurred in mice after the administration of LPS 5 mg/kg compared with the control group. However, the number of apoptotic cells in the brain of mice treated with A-438079 after LPS injection was significantly reduced comparing with the LPS group and the LPS + DMSO group. (Figures 5(e) and 5(f)). These results suggest that P2X7R 9 Behavioural Neurology inhibitor A-438079 can reduce intracellular Cleaved Caspase-9 and Cleaved Caspase-3 protein content and also curb the brain cell apoptosis during sepsis in mice.

Discussion
Being a syndrome involved multiple brain disorders, SAE is defined by many studies as cognitive impairment caused by severe peripheral sepsis or direct damage to brain tissue without evidence of direct infection in the brain (e.g., hepatic or renal encephalopathy) [31]. Cerebral dysfunction caused by septicemia has been a vital cause of delirium or altered mental state in critically ill patients [32]. Moreover, SAE can dramatically increase the mortality rate of sepsis patients [33,34]. The destruction of the blood-brain barrier is crucial in SAE, and it leads to the activation of a series of cell surface receptors (especially the P2X7R) in the brain, resulting in the damage of reactive oxygen species and the occurrence of apoptosis and necrosis in the brain [35].
Among the components of BBB, tight junction protein plays an important role in promoting the tight binding between cells and the transmission of information between cells. The relatively common tight junction proteins mainly include transmembrane proteins, such as Occludin, Claudin, and JAM-1, and cytoplasmic attachment proteins, such as ZO-1 [36]. Our study found that LPS-induced inflammatory stimulation activated P2X7R in the hippocampus of mice and further reduced tight junction protein expression, whereas when we used P2X7R inhibitor A-438079, the expression of ZO-1 and Occludin was significantly improved. Therefore, inhibition of P2X7R can protect the integrity of the blood-brain barrier to some extent and reduce the damage of brain cells.
Previous studies have found that the mitochondrial serine protease Omi/HtrA2 plays a critical role in the pathogen-esis of SAE [29,35], but their study was limited to Omi/ HtrA2 itself. In this study, we found that P2X7R is crucial for cytoplasmic translocation of Omi/HtrA2 under inflammatory stimulation, and there are two possible reasons. First, our experiment found that after activation of P2X7R, plenty of ROS would be produced in cells, causing severe damage to mitochondria in cells. This damage causes the opening of mitochondrial outer membrane channels (especially mPTP) [37], allowing Omi/HtrA2 to enter the cytoplasm. However, as a critical ROS producer, mitochondria also produce bountiful ROS when stimulated, thus, amplifying this effect. Second, as a nonselective cation channel on the cell surface, P2X7R will cause numerous cation influx after activation, break the ion balance inside and outside the cell, and also destroy the membrane potential of mitochondria, leading to cell apoptosis.
In this study, we found that after intraperitoneal injection of LPS, mice had significant cognitive dysfunction in the short term, especially spatial memory and directional sense, and all of them could be alleviated by the treatment of P2X7R inhibitor A-438079. Studies have found that the activation of P2X7R in the brain under inflammatory stimulation can not only result in the release of inflammatory factors (such as IL-6 and TNF-α) [6], but also activate some signaling pathways (such as NLRP3/IL-1β and STAT3) [38,39]. However, few studies have been conducted on the role of P2X7R in mediating apoptosis of brain cells under inflammatory conditions. Our study found a mitochondria-related apoptosis pathway caused by P2X7R activation, providing some clues to the possible pathogenesis of SAE.
To sum up, our data demonstrate that P2X7R plays a damaging role in the pathogenesis of SAE. Besides, we provided some valuable evidence, for example, P2X7R activates brain cells to produce a lot of ROS in vivo sepsis, mediates mitochondrial damage and Omi/HtrA2 translocation from  Figure 6: LPS stimulated cells to induce the P2X7R-mediated intracellular Omi/HtrA2 apoptosis signaling pathway. Under the stress stimulation of LPS, mitochondria in cells will produce a large amount of ATP and activate P2X7R on the cell surface. The activated P2X7R will cause a large amount of Ca2+ influx, and then the imbalance of intracellular Ca2+ homeostasis will lead to the production of a large amount of intracellular ROS and further cause mitochondrial damage. However, Ca2+ overload in mitochondria will further increase the production of ROS and cause the transfer of OMI/HtrA2 in the damaged mitochondrial membrane space into the cytoplasm. Omi/HtrA2 in the cytoplasm can crack the apoptosis inhibiting protein XIAP, which leads to the decrease of XIAP inhibiting caspase-3 and caspase-9 in cells, and promotes cell apoptosis. mitochondria to cytoplasm, thereby promoting the cleavage of the intracellular apoptosis-inhibiting protein XIAP through Omi/HtrA2, and increases the expression of proapoptotic protein such as cleaved-Caspase-3 ( Figure 6), ultimately leading to cognitive impairment. These findings provide potential therapeutic targets for the treatment of encephalopathy caused by severe infectious diseases and probably reduce the clinical mortality of SAE patients in the future.

Conclusion
In this study, we found that P2X7R inhibitors can protect the blood-brain barrier in mice and alleviate the ROS production in brain cells induced by LPS stimulation. In addition, A-438079 also inhibits cell apoptosis by blocking mitochondrial serine protease transfer from mitochondria into the cytoplasm. Moreover, we also demonstrated that P2X7R inhibitors can significantly treat short-term cognitive dysfunction caused by LPS in mice. These findings further demonstrate the great importance of P2X7R in the clinical treatment of SAE.

Data Availability
The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest
All the authors declare that there are no financial or nonfinancial competing interests regarding the publication of this paper.